Otonomy Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Back to Jobs

OTIVIDEX™  Phase 3 trial in Ménière’s disease on track for results in first half 2020 OTO-313 Phase 1/2 trial in tinnitus expected to start in second quarter of 2019 OTO-413 Phase 1/2 trial in hearing loss expected to start in third quarter of 2019 $15 million term loan completed to extend cash

Apply Now